Neurodegenerative Disease Market Share

Statistics for the 2023 & 2024 Neurodegenerative Disease market share, created by Mordor Intelligence™ Industry Reports. Neurodegenerative Disease share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Developmental Anomalities Research Neurodegenerative Disease Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Neurodegenerative Disease Industry

The market is semi-consolidated due to the presence of a few major market players. The major players adopt strategic methods such as mergers and acquisitions, partnerships and collaborations, investments in research and development activities, and new product launches to withstand the global competitive rivalry. Some major market players are AbbVie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Pfizer Inc., Teva Pharmaceuticals, Novartis AG, and UCB SA.

Neurodegenerative Disease Market Leaders

  1. Boehringer Ingelheim International GmbH

  2. UCB SA

  3. Novartis AG

  4. Teva Pharmaceutical

  5. Merck & Co Inc.

*Disclaimer: Major Players sorted in no particular order

Neurodegenerative Disease Market Concentration

Neurodegenerative Diseases Market Report Snapshots

Neurodegenerative Disease Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)